Align Technology (ALGN) Competitors $204.96 +2.78 (+1.38%) As of 03:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALGN vs. DXCM, HQY, HSIC, MEDP, QTRX, CAH, HAE, MCK, RMD, and WSTShould you be buying Align Technology stock or one of its competitors? The main competitors of Align Technology include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Medpace (MEDP), Quanterix (QTRX), Cardinal Health (CAH), Haemonetics (HAE), McKesson (MCK), ResMed (RMD), and West Pharmaceutical Services (WST). These companies are all part of the "medical" sector. Align Technology vs. Its Competitors DexCom HealthEquity Henry Schein Medpace Quanterix Cardinal Health Haemonetics McKesson ResMed West Pharmaceutical Services DexCom (NASDAQ:DXCM) and Align Technology (NASDAQ:ALGN) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability. Does the media refer more to DXCM or ALGN? In the previous week, DexCom had 4 more articles in the media than Align Technology. MarketBeat recorded 24 mentions for DexCom and 20 mentions for Align Technology. Align Technology's average media sentiment score of 1.02 beat DexCom's score of 0.79 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 12 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 12 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend DXCM or ALGN? DexCom presently has a consensus price target of $99.60, suggesting a potential upside of 12.32%. Align Technology has a consensus price target of $242.92, suggesting a potential upside of 18.52%. Given Align Technology's higher possible upside, analysts plainly believe Align Technology is more favorable than DexCom.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DexCom 0 Sell rating(s) 4 Hold rating(s) 16 Buy rating(s) 2 Strong Buy rating(s) 2.91Align Technology 1 Sell rating(s) 4 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.67 Is DXCM or ALGN more profitable? DexCom has a net margin of 12.90% compared to Align Technology's net margin of 10.29%. DexCom's return on equity of 30.05% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets DexCom12.90% 30.05% 10.00% Align Technology 10.29%13.52%8.36% Which has stronger valuation & earnings, DXCM or ALGN? DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDexCom$4.03B8.62$576.20M$1.3466.17Align Technology$4.00B3.72$421.36M$5.4937.33 Do institutionals & insiders hold more shares of DXCM or ALGN? 97.8% of DexCom shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 0.3% of DexCom shares are held by insiders. Comparatively, 0.7% of Align Technology shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, DXCM or ALGN? DexCom has a beta of 1.44, meaning that its stock price is 44% more volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500. SummaryDexCom beats Align Technology on 12 of the 17 factors compared between the two stocks. Get Align Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALGN vs. The Competition Export to ExcelMetricAlign TechnologyMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.87B$15.90B$5.72B$9.52BDividend YieldN/A1.42%4.60%3.99%P/E Ratio37.3519.0728.0720.02Price / Sales3.722.40462.58104.32Price / Cash22.7117.5736.5558.97Price / Book3.974.018.645.90Net Income$421.36M$430.42M$3.24B$258.50M7 Day Performance7.44%5.53%4.08%2.12%1 Month Performance9.52%5.65%10.68%12.62%1 Year Performance-9.33%25.04%34.47%19.25% Align Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALGNAlign Technology4.6491 of 5 stars$204.96+1.4%$242.92+18.5%-17.4%$14.87B$4.00B37.3520,945Positive NewsUpcoming EarningsDXCMDexCom4.7207 of 5 stars$84.03+0.2%$99.60+18.5%-22.5%$32.95B$4.03B62.7110,300Upcoming EarningsHQYHealthEquity3.2357 of 5 stars$97.08-0.6%$118.55+22.1%+20.8%$8.39B$1.20B70.863,120Positive NewsHSICHenry Schein3.6423 of 5 stars$69.070.0%$78.36+13.5%+3.3%$8.41B$12.67B21.5825,000Analyst ForecastMEDPMedpace3.6992 of 5 stars$308.88-1.0%$344.82+11.6%+19.3%$8.88B$2.11B23.585,900Positive NewsEarnings ReportAnalyst ForecastAnalyst RevisionHigh Trading VolumeQTRXQuanterix2.6502 of 5 stars$5.18-3.5%$13.50+160.6%-64.1%$258.74M$137.42M-3.98460Positive NewsCAHCardinal Health4.8382 of 5 stars$158.66-0.6%$158.07-0.4%+63.5%$37.87B$222.29B24.7548,900Positive NewsAnalyst RevisionHAEHaemonetics4.9081 of 5 stars$73.70+1.6%$97.30+32.0%-18.9%$3.54B$1.36B22.263,023MCKMcKesson4.6008 of 5 stars$711.19+0.2%$710.17-0.1%+20.4%$88.98B$359.05B27.5345,000Positive NewsRMDResMed3.6109 of 5 stars$261.10+1.2%$263.00+0.7%+32.6%$38.28B$5.02B29.309,980Positive NewsUpcoming EarningsWSTWest Pharmaceutical Services4.4602 of 5 stars$210.56-0.2%$320.00+52.0%-13.9%$15.13B$2.89B33.0510,600Trending NewsEarnings ReportDividend IncreaseAnalyst Forecast Related Companies and Tools Related Companies DXCM Alternatives HQY Alternatives HSIC Alternatives MEDP Alternatives QTRX Alternatives CAH Alternatives HAE Alternatives MCK Alternatives RMD Alternatives WST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALGN) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Align Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Align Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
